Literature DB >> 21107844

Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy.

Adam W Levinson1, Hugh J Lavery, Nicholas T Ward, Li-Ming Su, Christian P Pavlovich.   

Abstract

OBJECTIVES: Outcome measures following radical prostatectomy are not standardized. Though excellent potency rates are widely reported, few studies address a return to baseline function. We analyze validated sexual health-related quality-of-life outcomes by a strict definition, a return to baseline function, and compare them to less stringent, yet more frequently referenced, categorical definitions of potency.
METHODS: Patients undergoing laparoscopic radical prostatectomy from April 2001 to September 2007 completed the Expanded Prostate Cancer Index Composite (EPIC) questionnaire at baseline and 3, 6, 12, and 24 months postoperatively. We defined a return to baseline as a recovery to greater than one-half standard deviation of the studied population below the patient's own baseline (clinically detectable threshold). We compared these outcomes to a categorical definition of potency involving intercourse frequency. To limit confounders, we performed subset analyses of preoperatively potent men who received bilateral nerve preservation. Factors predictive of return to baseline function were assessed in multivariable analysis.
RESULTS: A total of 568 patients met inclusion criteria. Mean age and follow-up were 57.2 years and 16.9 months, respectively. Using the categorical definition, 85% of preoperatively potent men with bilateral nerve preservation were "potent" at 24 months; however, only 27% returned to their baseline sexual function. In multivariable analyses baseline function, number of nerves spared, and age were independent predictors of a return to baseline function.
CONCLUSION: While most preoperatively potent men who receive bilateral nerve preservation engage in intercourse postoperatively, few return to their baseline sexual function. We believe that these data provide context for the expectations of patients who elect extirpative therapy.

Entities:  

Mesh:

Year:  2010        PMID: 21107844     DOI: 10.1007/s00345-010-0616-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  25 in total

1.  Quality of life and prostate cancer treatment.

Authors:  M J Barry
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Simple as possible? Or too simple? Possible limits to the universality of the one half standard deviation.

Authors:  Dorcas E Beaton
Journal:  Med Care       Date:  2003-05       Impact factor: 2.983

3.  Robotic-assisted prostatectomy: is there truth in advertising?

Authors:  James A Eastham
Journal:  Eur Urol       Date:  2008-07-21       Impact factor: 20.096

4.  Measuring disease-specific quality of life in clinical trials.

Authors:  G H Guyatt; C Bombardier; P X Tugwell
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262

5.  Comparison of validated instruments measuring sexual function in men.

Authors:  Adam W Levinson; Nicholas T Ward; Martin G Sanda; Lynda Z Mettee; John T Wei; Li-Ming Su; Mark S Litwin; Christian P Pavlovich
Journal:  Urology       Date:  2010-06-22       Impact factor: 2.649

6.  Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy.

Authors:  Zvi Symon; Stephanie Daignault; Rachel Symon; Rodney L Dunn; Martin G Sanda; Howard M Sandler
Journal:  Urology       Date:  2006-12-04       Impact factor: 2.649

7.  Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Authors:  Steven B Zeliadt; Scott D Ramsey; David F Penson; Ingrid J Hall; Donatus U Ekwueme; Leonard Stroud; Judith W Lee
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

8.  Impotence following radical prostatectomy: insight into etiology and prevention.

Authors:  P C Walsh; P J Donker
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

9.  Life after radical prostatectomy: a longitudinal study.

Authors:  M S Litwin; G Y Melmed; T Nakazon
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

10.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

View more
  7 in total

1.  Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.

Authors:  Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-06-27       Impact factor: 3.894

Review 2.  Erection rehabilitation following prostatectomy--current strategies and future directions.

Authors:  Nikolai A Sopko; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-15       Impact factor: 14.432

Review 3.  [Radical prostatectomy in a certified prostate cancer center: medical treatment and outcome].

Authors:  J Kranz; O Deserno; K Fischer; P Anheuser; B Reisch; J Steffens
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

4.  Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.

Authors:  Alan Katz; Montserrat Ferrer; José Francisco Suárez
Journal:  Radiat Oncol       Date:  2012-11-20       Impact factor: 3.481

5.  Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer.

Authors:  Kazuhiro Fukuda; Satoru Muto; Toshiyuki China; Hiroki Koyasu; Yasuhiro Noma; Takeshi Ashizawa; Hisashi Hirano; Kosuke Kitamura; Fumitaka Shimizu; Masayoshi Nagata; Shuji Isotani; Shigeo Horie
Journal:  Prostate Int       Date:  2021-09-04

6.  Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial.

Authors:  Jane M Robertson; Gerard J Molloy; Prasad R Bollina; Daniel M Kelly; S Alan McNeill; Liz Forbat
Journal:  Trials       Date:  2014-05-24       Impact factor: 2.279

Review 7.  Prevention and management of post prostatectomy erectile dysfunction.

Authors:  Andrea Salonia; Giulia Castagna; Paolo Capogrosso; Fabio Castiglione; Alberto Briganti; Francesco Montorsi
Journal:  Transl Androl Urol       Date:  2015-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.